Ming‐Yung Lee

1.2k total citations
56 papers, 805 citations indexed

About

Ming‐Yung Lee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming‐Yung Lee has authored 56 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming‐Yung Lee's work include HER2/EGFR in Cancer Research (9 papers), Ovarian cancer diagnosis and treatment (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ming‐Yung Lee is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Ovarian cancer diagnosis and treatment (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Ming‐Yung Lee collaborates with scholars based in Taiwan, United States and China. Ming‐Yung Lee's co-authors include Susannah L. Scott, Se Gyu Jang, Anthony J. Crisci, Mark H. Tucker, James A. Dumesic, Chih‐Ping Han, Wan‐Ru Chao, James Cheng‐Chung Wei, Shin‐Nan Cheng and Yu‐Pin Cheng and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and ACS Catalysis.

In The Last Decade

Ming‐Yung Lee

52 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Yung Lee Taiwan 15 166 153 115 107 93 56 805
Qiling Li China 22 142 0.9× 54 0.4× 263 2.3× 40 0.4× 132 1.4× 105 1.3k
Chunxiao Wang China 25 183 1.1× 175 1.1× 609 5.3× 55 0.5× 77 0.8× 96 1.9k
Ninghan Tang China 18 93 0.6× 113 0.7× 159 1.4× 76 0.7× 182 2.0× 56 952
Paulos Yohannes United States 21 55 0.3× 98 0.6× 204 1.8× 73 0.7× 104 1.1× 43 1.4k
Lihua Zeng China 18 143 0.9× 43 0.3× 157 1.4× 73 0.7× 57 0.6× 48 684
Qi Tang China 16 311 1.9× 72 0.5× 273 2.4× 61 0.6× 36 0.4× 54 1.1k
Roger Ackroyd United Kingdom 25 285 1.7× 625 4.1× 169 1.5× 33 0.3× 101 1.1× 85 2.7k
Katarina Jeremić Serbia 15 124 0.7× 89 0.6× 67 0.6× 100 0.9× 54 0.6× 96 918
Mahboubeh Rostami Iran 23 158 1.0× 333 2.2× 437 3.8× 305 2.9× 104 1.1× 99 1.5k
Mei Hu China 15 52 0.3× 74 0.5× 191 1.7× 117 1.1× 49 0.5× 51 696

Countries citing papers authored by Ming‐Yung Lee

Since Specialization
Citations

This map shows the geographic impact of Ming‐Yung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yung Lee more than expected).

Fields of papers citing papers by Ming‐Yung Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Yung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yung Lee. The network helps show where Ming‐Yung Lee may publish in the future.

Co-authorship network of co-authors of Ming‐Yung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Yung Lee. A scholar is included among the top collaborators of Ming‐Yung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Yung Lee. Ming‐Yung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chao, Wan‐Ru, et al.. (2024). HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(10). 7615–7622. 3 indexed citations
2.
Lee, Ming‐Yung, et al.. (2017). A Two-Stage Latent Variable Estimation Procedure for Time-Censored Accelerated Degradation Tests. IEEE Transactions on Reliability. 66(4). 1266–1279. 8 indexed citations
5.
Tsai, Hui‐Yu, et al.. (2014). Ambient and Personal Effective Dose Assessment at the International Arrival Hall of Taichung Airport in Taiwan. Archives of Environmental & Occupational Health. 70(5). 265–271. 4 indexed citations
6.
Chao, Wan‐Ru, Ming‐Yung Lee, Chi‐Kuan Chen, et al.. (2013). HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Human Pathology. 45(4). 810–816. 20 indexed citations
7.
Lee, Chien‐Ying, et al.. (2013). Efficacy and safety of herbal medicine yun-cai tea in the treatment of hyperlipidemia: A double-blind placebo-controlled clinical trial. Chinese Journal of Integrative Medicine. 21(8). 587–593. 2 indexed citations
8.
Pai, Hsiang‐Chu, Sheuan Lee, Wen‐Jiuan Yen, & Ming‐Yung Lee. (2013). Testing of the Factor Structure of the Sexual Health Knowledge Measure With Young Adolescent Taiwanese Girls. Health Care For Women International. 34(10). 878–890. 2 indexed citations
9.
Lee, Ming‐Yung, et al.. (2012). Determinants of emergency medical utilization among the elderly population in Taiwan: A national longitudinal cohort study. Archives of Gerontology and Geriatrics. 56(2). 364–369. 9 indexed citations
10.
Lin, Wea‐Lung, Wu‐Hsien Kuo, Fong‐Lin Chen, et al.. (2011). Identification of the Coexisting HER2 Gene Amplification and Novel Mutations in the HER2 Protein-Overexpressed Mucinous Epithelial Ovarian Cancer. Annals of Surgical Oncology. 18(8). 2388–2394. 33 indexed citations
11.
Lee, Ming‐Yung, Shin‐Nan Cheng, Shyi-Jou Chen, et al.. (2011). Polymorphisms of the β2-Adrenergic Receptor Correlated to Nocturnal Asthma and the Response of Terbutaline Nebulizer. Pediatrics & Neonatology. 52(1). 18–23. 18 indexed citations
12.
Lee, Ming‐Yung & Susannah L. Scott. (2011). Quantitative Investigation of a Hybrid Ziegler–Natta Catalyst Support Prepared by Grafting Di(n‐butyl)magnesium onto Partially Dehydroxylated Silica. Chemistry - A European Journal. 17(16). 4632–4639. 9 indexed citations
13.
Hsu, Jeng‐Dong, Chung‐Chin Yao, Ming‐Yung Lee, et al.. (2010). True Cytokeratin 8/18 Immunohistochemistry is of No Use in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study. International Journal of Gynecological Pathology. 29(3). 282–289. 5 indexed citations
14.
Lee, Shu‐Hsin, Ming‐Yung Lee, Tung‐liang Chiang, Maw‐Sheng Lee, & Meng‐Chih Lee. (2010). Child growth from birth to 18 months old born after assisted reproductive technology—Results of a national birth cohort study. International Journal of Nursing Studies. 47(9). 1159–1166. 23 indexed citations
16.
Lee, Ming‐Yung, et al.. (2009). Lipid-Lowering Effect of Nattokinase in Patients with Primary Hypercholesterolemia. Zhōnghuá mínguó xīnzàngxué huì zázhì. 25(1). 26–30. 16 indexed citations
17.
Pai, Hsiang‐Chu, Ming‐Yung Lee, & Sheuan Lee. (2009). Obesity and Perimenopausal Symptoms in Mid-life Women in Southern Taiwan. Tzu Chi Medical Journal. 21(4). 289–295.
18.
Han, Chih‐Ping, Ming‐Yung Lee, Yeu‐Sheng Tyan, et al.. (2009). p16INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(4). 353–361. 6 indexed citations
20.
Jiao, Jian, Ming‐Yung Lee, Craig E. Barnes, & Edward W. Hagaman. (2008). 119Sn NMR chemical shift tensors in anhydrous and hydrated Si8O20(SnMe3)8 crystals. Magnetic Resonance in Chemistry. 46(7). 690–692. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026